(OCI) OCI - Overview
Sector: Basic MaterialsIndustry: Specialty Chemicals | Exchange AS (Netherlands) | Currency EUR | Market Cap: 754m | Total Return -24.4% in 12m
Stock: Fertilizers, Chemicals, Fuels, Storage, Distribution
Total Rating 18
Risk 32
Buy Signal -0.84
| Risk 5d forecast | |
|---|---|
| Volatility | 37.5% |
| Relative Tail Risk | -24.6% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.53 |
| Alpha | -21.81 |
| Character TTM | |
|---|---|
| Beta | -0.402 |
| Beta Downside | -1.167 |
| Drawdowns 3y | |
|---|---|
| Max DD | 47.59% |
| CAGR/Max DD | -0.21 |
EPS (Earnings per Share)
Revenue
Description: OCI OCI March 05, 2026
OCI N.V. is a Netherlands-based producer and distributor of hydrogen and natural gas-based products. Its primary markets are agricultural, transportation, and industrial sectors across six continents.
The companys product portfolio includes various fertilizers like urea and ammonia, industrial chemicals such as methanol and melamine, and renewable/lower carbon ammonia. OCI also provides ammonia storage and shipment services in Rotterdam. The agricultural chemicals sector is cyclical, influenced by crop prices and energy costs.
OCI operates through distinct segments: Methanol US, Methanol Europe, and Nitrogen Europe. This structure allows for regional focus and specialized product offerings. Understanding the company’s revenue streams and segment performance is crucial; ValueRay can provide detailed financial breakdowns.
Headlines to watch out for
- Natural gas prices directly impact production costs and profitability
- Agricultural demand for fertilizers drives nitrogen product sales
- Methanol prices fluctuate with global industrial chemical demand
- Regulatory shifts in carbon emissions affect hydrogen-based product viability
- Shipping and storage service revenue provides stable income stream
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: 5.31b TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -8.07 > 1.0 |
| NWC/Revenue: 188.4% < 20% (prev 77.06%; Δ 111.3% < -1%) |
| CFO/TA -0.12 > 3% & CFO -407.4m > Net Income 5.31b |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.65 > 1.5 & < 3 |
| Outstanding Shares: last quarter (210.9m) vs 12m ago -0.06% < -2% |
| Gross Margin: -19.77% > 18% (prev 0.08%; Δ -1.99k% > 0.5%) |
| Asset Turnover: 8.53% > 50% (prev 28.63%; Δ -20.10% > 0%) |
| Interest Coverage Ratio: -2.43 > 6 (EBITDA TTM -212.0m / Interest Expense TTM 107.4m) |
Altman Z'' 2.22
| A: 0.28 (Total Current Assets 2.55b - Total Current Liabilities 1.54b) / Total Assets 3.54b |
| B: 0.14 (Retained Earnings 479.0m / Total Assets 3.54b) |
| C: -0.04 (EBIT TTM -260.7m / Avg Total Assets 6.26b) |
| D: 0.18 (Book Value of Equity 303.9m / Total Liabilities 1.67b) |
| Altman-Z'' Score: 2.22 = BBB |
Beneish M 1.00
| DSRI: 8.74 (Receivables 693.3m/382.1m, Revenue 534.1m/2.57b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 2.37 (AQ_t 0.11 / AQ_t-1 0.05) |
| SGI: 0.21 (Revenue 534.1m / 2.57b) |
| TATA: 1.62 (NI 5.31b - CFO -407.4m) / TA 3.54b) |
| Beneish M-Score: 5.25 (Cap -4..+1) = D |
What is the price of OCI shares?
As of March 25, 2026, the stock is trading at EUR 3.18 with a total of 299,677 shares traded.
Over the past week, the price has changed by -8.73%, over one month by -9.36%, over three months by +5.16% and over the past year by -24.37%.
Over the past week, the price has changed by -8.73%, over one month by -9.36%, over three months by +5.16% and over the past year by -24.37%.
Is OCI a buy, sell or hold?
OCI has no consensus analysts rating.
What are the forecasts/targets for the OCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 3.9 | 23.6% |
| Analysts Target Price | - | - |
OCI Fundamental Data Overview March 22, 2026
Market Cap USD = 754.1m (652.2m EUR * 1.1562 EUR.USD)
Market Cap USD = 754.1m (652.2m EUR * 1.1562 EUR.USD)
P/E Forward = 30.2115
P/S = 0.6006
P/B = 0.4012
Revenue TTM = 534.1m USD
EBIT TTM = -260.7m USD
EBITDA TTM = -212.0m USD
Long Term Debt = 114.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 755.8m USD (from shortTermDebt, last quarter)
Debt = 853.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -915.7m USD (from netDebt column, last quarter)
Enterprise Value = -161.6m USD (754.1m + Debt 853.7m - CCE 1.77b)
Interest Coverage Ratio = -2.43 (Ebit TTM -260.7m / Interest Expense TTM 107.4m)
EV/FCF = 0.61x (Enterprise Value -161.6m / FCF TTM -264.2m)
FCF Yield = 163.5% (FCF TTM -264.2m / Enterprise Value -161.6m)
FCF Margin = -49.47% (FCF TTM -264.2m / Revenue TTM 534.1m)
Net Margin = 994.6% (Net Income TTM 5.31b / Revenue TTM 534.1m)
Gross Margin = -19.77% ((Revenue TTM 534.1m - Cost of Revenue TTM 639.7m) / Revenue TTM)
Gross Margin QoQ = -5.66% (prev -5.66%)
Tobins Q-Ratio = -0.05 (set to none) (Enterprise Value -161.6m / Total Assets 3.54b)
Interest Expense / Debt = 6.29% (Interest Expense 53.7m / Debt 853.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -206.0m (EBIT -260.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.65 (Total Current Assets 2.55b / Total Current Liabilities 1.54b)
Debt / Equity = 0.46 (Debt 853.7m / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 4.32 (negative EBITDA) (Net Debt -915.7m / EBITDA -212.0m)
Debt / FCF = 3.47 (negative FCF - burning cash) (Net Debt -915.7m / FCF TTM -264.2m)
Total Stockholder Equity = 2.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 84.87% (Net Income 5.31b / Total Assets 3.54b)
RoE = 258.7% (Net Income TTM 5.31b / Total Stockholder Equity 2.05b)
RoCE = -12.03% (EBIT -260.7m / Capital Employed (Equity 2.05b + L.T.Debt 114.7m))
RoIC = -7.91% (negative operating profit) (NOPAT -206.0m / Invested Capital 2.60b)
WACC = 4.78% (E(754.1m)/V(1.61b) * Re(4.57%) + D(853.7m)/V(1.61b) * Rd(6.29%) * (1-Tc(0.21)))
Discount Rate = 4.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF] Fair Price = unknown (Cash Flow -264.2m)
EPS Correlation: -73.77 | EPS CAGR: -15.42% | SUE: 0.0 | # QB: 0
Revenue Correlation: -56.59 | Revenue CAGR: -36.29% | SUE: 0.28 | # QB: 0
EPS current Year (2026-12-31): EPS=0.01 | Chg7d=+0.077 | Chg30d=+0.077 | Revisions Net=+0 | Growth EPS=+106.3% | Growth Revenue=-28.5%
EPS next Year (2027-12-31): EPS=0.06 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+462.5% | Growth Revenue=-15.2%
Market Cap USD = 754.1m (652.2m EUR * 1.1562 EUR.USD)
P/E Forward = 30.2115
P/S = 0.6006
P/B = 0.4012
Revenue TTM = 534.1m USD
EBIT TTM = -260.7m USD
EBITDA TTM = -212.0m USD
Long Term Debt = 114.7m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 755.8m USD (from shortTermDebt, last quarter)
Debt = 853.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -915.7m USD (from netDebt column, last quarter)
Enterprise Value = -161.6m USD (754.1m + Debt 853.7m - CCE 1.77b)
Interest Coverage Ratio = -2.43 (Ebit TTM -260.7m / Interest Expense TTM 107.4m)
EV/FCF = 0.61x (Enterprise Value -161.6m / FCF TTM -264.2m)
FCF Yield = 163.5% (FCF TTM -264.2m / Enterprise Value -161.6m)
FCF Margin = -49.47% (FCF TTM -264.2m / Revenue TTM 534.1m)
Net Margin = 994.6% (Net Income TTM 5.31b / Revenue TTM 534.1m)
Gross Margin = -19.77% ((Revenue TTM 534.1m - Cost of Revenue TTM 639.7m) / Revenue TTM)
Gross Margin QoQ = -5.66% (prev -5.66%)
Tobins Q-Ratio = -0.05 (set to none) (Enterprise Value -161.6m / Total Assets 3.54b)
Interest Expense / Debt = 6.29% (Interest Expense 53.7m / Debt 853.7m)
Taxrate = 21.0% (US default 21%)
NOPAT = -206.0m (EBIT -260.7m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.65 (Total Current Assets 2.55b / Total Current Liabilities 1.54b)
Debt / Equity = 0.46 (Debt 853.7m / totalStockholderEquity, last quarter 1.86b)
Debt / EBITDA = 4.32 (negative EBITDA) (Net Debt -915.7m / EBITDA -212.0m)
Debt / FCF = 3.47 (negative FCF - burning cash) (Net Debt -915.7m / FCF TTM -264.2m)
Total Stockholder Equity = 2.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 84.87% (Net Income 5.31b / Total Assets 3.54b)
RoE = 258.7% (Net Income TTM 5.31b / Total Stockholder Equity 2.05b)
RoCE = -12.03% (EBIT -260.7m / Capital Employed (Equity 2.05b + L.T.Debt 114.7m))
RoIC = -7.91% (negative operating profit) (NOPAT -206.0m / Invested Capital 2.60b)
WACC = 4.78% (E(754.1m)/V(1.61b) * Re(4.57%) + D(853.7m)/V(1.61b) * Rd(6.29%) * (1-Tc(0.21)))
Discount Rate = 4.57% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares Correlation 3-Years: 33.33 | Cagr: 0.01%
[DCF] Fair Price = unknown (Cash Flow -264.2m)
EPS Correlation: -73.77 | EPS CAGR: -15.42% | SUE: 0.0 | # QB: 0
Revenue Correlation: -56.59 | Revenue CAGR: -36.29% | SUE: 0.28 | # QB: 0
EPS current Year (2026-12-31): EPS=0.01 | Chg7d=+0.077 | Chg30d=+0.077 | Revisions Net=+0 | Growth EPS=+106.3% | Growth Revenue=-28.5%
EPS next Year (2027-12-31): EPS=0.06 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=+0 | Growth EPS=+462.5% | Growth Revenue=-15.2%